# Effects of PGI2 Analogue Use on the Development of Chronic Allograft Nephropathy

> **NCT01056835** · PHASE3 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Chronic Allograft Nephropathy

## Interventions

- **DRUG:** prostaglandin I2 analogue

## Key facts

- **NCT ID:** NCT01056835
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2013-12
- **Final completion:** 2014-06
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2015-05-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01056835

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01056835, "Effects of PGI2 Analogue Use on the Development of Chronic Allograft Nephropathy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01056835. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*